Low Thromboembolism and Pump Thrombosis With the HeartMate II Left Ventricular Assist Device: Analysis of Outpatient Anti-coagulation

Andrew Boyle(Thomas Jefferson University), Ranjit John(University of Minnesota), Francis D. Pagani(Michigan Medicine), Stuart D. Russell(Duke Medical Center), Nader Moazami(NYU Langone Health), Jeffrey J. Teuteberg(Stanford University), O.H. Frazier(Unknown), Mark S. Slaughter(University of Louisville), David J. Farrar(JTEC Corporation (Japan)), Gerald J. Heatley
The Journal of Heart and Lung Transplantation
August 27, 2009
10.1016/j.healun.2009.05.018
Cited by 303

Related Papers

Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial
|The Lancet|2020|1k
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711
Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation
|Circulation|2012|655